Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · Real-Time Price · USD
2.420
+0.070 (2.98%)
At close: Oct 8, 2025, 4:00 PM EDT
2.380
-0.040 (-1.66%)
After-hours: Oct 8, 2025, 7:07 PM EDT
Phio Pharmaceuticals Market Cap
Phio Pharmaceuticals has a market cap or net worth of $13.86 million as of October 8, 2025. Its market cap has increased by 357.42% in one year.
Market Cap
13.86M
Enterprise Value
3.08M
1-Year Change
357.42%
Ranking
Category
Stock Price
$2.42
Market Cap Chart
Since May 10, 2012, Phio Pharmaceuticals's market cap has decreased from $42.54T to $13.86M, a decrease of -100.00%. That is a compound annual growth rate of -67.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 13.46M | 331.57% |
| Dec 31, 2024 | 3.12M | 67.92% |
| Dec 29, 2023 | 1.86M | -63.48% |
| Dec 30, 2022 | 5.08M | -62.43% |
| Dec 31, 2021 | 13.53M | -12.96% |
| Dec 31, 2020 | 15.55M | 146.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |